Imitrex
Product Images NDC 54868-5118

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Imitrex (NDC 54868-5118). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

25 mg Label.jpg (3777)

IMITREX 25MG label distributed by Physicians Total Care, Inc. The label shows the lot number and expiration date in a simple black text on white background format. It includes a barcode and the National Drug Code (NDC) 54868-3777-0. Manufacturer is listed as Glaxo Smith Kline with a research triangle number visible.*

FDA Label Image

50 mg Label.jpg (3852)

Packaging label for IMITREX 50 mg tablet distributed by Physicians Total Care, Inc. in Tulsa, OK. The label includes lot number, expiration date of 01/60, manufacturer GlaxoSmithKline in Research Triangle NC, and a barcode with readable numbers.*

FDA Label Image

Imitrex Tablets Chemical Structure (419cf1ac 93c8 4975 B0d2 86b8decaeccd 01)

Chemical structure of the active ingredient in IMITREX, showing the molecular arrangement including indole and carboxyl groups.*

FDA Label Image

Figure 1. Estimated Probability Of Achieving Initial Headache Response Within 240 Minutes* (419cf1ac 93c8 4975 B0d2 86b8decaeccd 02)

A line graph depicting the estimated probability of response over time in minutes from the first dose for IMITREX at doses of 25 mg, 50 mg, and 100 mg compared to a placebo. The graph shows response probabilities increasing over a 240-minute period, with higher doses generally corresponding to higher probabilities.*

FDA Label Image

Figure 2. The Estimated Probability Of Patients Taking A Second Dose Or Other Medication For Migraine Over The 24 Hours Following The Initial Dose Of Study Treatment* (419cf1ac 93c8 4975 B0d2 86b8decaeccd 03)

A line chart comparing the estimated probability of renal jailer rescue over 24 hours after the final dose for placebo and three doses (25 mg, 50 mg, 100 mg) of a medication. The vertical axis represents the probability percentage, and the horizontal axis shows time in hours post-dose. Higher doses show increased probability over time compared to placebo.*

FDA Label Image

100 mg Label.jpg (5118)

Packaging label for IMITREX 100 mg distributed by Physicians Total Care, Inc. The label includes the lot number and an expiration date, along with a barcode and the manufacturer identified as Glaxo Smith Kline in Research Triangle, NC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.